Sting activating nanovaccine for immunotherapy Grant US-11376324-B2 United States of America 05 Jul 2022
STING ACTIVATING NANOVACCINE FOR IMMUNOTHERAPY Application EP-3423044-A4 European Patent Office 20 Nov 2019